Department of Hepatobiliary Surgery, Affiliated Foshan Hospital, Southern Medical University (The Second People’s Hospital of Foshan), Foshan 528000, China
Auto-generated profile, based on publicly available information
Qing Wu
Department of Hepatobiliary Surgery, Affiliated Foshan Hospital, Southern Medical University (The Second People’s Hospital of Foshan), Foshan 528000, China
A fluorine-containing methylacrylate copolymer latex has been synthesized by emulsion polymerization and was used as a water- and oil-repellent agent to treat some pure cotton woven fabrics at different dry and curing temperature. The treated cotton fabric surfaces were investigated by attenuated total reflectance infrared analysis and angle-dependent X-ray photoelectron spectroscopy directly. The analysis results could agree with the fluorine-containing copolymer real situation on the fabrics surface much more, and could indicate, factually, surface properties of treated or modified material rather than copolymer film. It was found that fluorine elements are enriched at the air-polymer interface and fluorine content of the treated cotton fabrics surface decreases with increasing analysis depth, which depends on heating and cooling experience, such as annealing and quenching. Furthermore, the results showed that almost the same effect can be attained using this copolymer curing from 100°C to 175°C; the relatively low curing temperature is very valuable and advantageous for some fabrics which would yellow easily at higher temperatures. The water- and oil-repellency grade of treated cotton fabrics by the fluorine-containing methylacrylate copolymer latex increases with an increase on fluorine content on the surface.
Background. Hepatocellular carcinoma (HCC) is the sixth most common tumor worldwide. Additionally, deletion of RAPGEF2 plays a critical role in CNV and related to tumor immune microenvironment, whereas the prognostic potential of RAPGEF2 in HCC patient needs to be explored. Methods. We looked for prognostic potential genes in HCC using a variety of R programs. Then, using the LASSO Cox regression, we thoroughly evaluated and integrated the RAPGEF2-related genes from TCGA database. Meanwhile, utilizing TCGA and ICGA databases, the link between RAPGEF2 and immunotherapy response in HCC was studied. In vivo, the effect of RAPGEF2 on tumor development and the capacity of natural killer (NK) cells to recruit were confirmed. To ascertain the connection between RAPGEF2-related genes and the prognosis of HCC, a prognostic model was created and validated. Result. We demonstrated RAPGEF2 has a differential expression, and patients with deletion of RAPGEF2 gene get shorter survival in HCC. Additionally, the tissues without RAPGEF2 have a weaker ability to recruit the NK cells and response to immunotherapy. After that, we scoured the database for eight RAPGEF2-related genes linked with a better prognosis in HCC patients. Additionally, silencing RAPGEF2 accelerated tumor development in the HCC mouse model and decreased CD56+ NK cell recruitment in HCC tissues. TCGA database was used to classify patients into low- and high-risk categories based on the expression of related genes. Patients in the low-risk group had a significantly greater overall survival than those in the high-risk group ( ). Meanwhile, the low-risk group demonstrated connections with the NK cell and immunotherapy response. Finally, the prognostic nomogram showed a high sensitivity and specificity for predicting the survival of HCC patients at 1, 2, and 3 years. Conclusion. The prognostic model based on RAPGEF2 and RAPGEF2-related genes showed an excellent predictive performance in terms of prognosis and immunotherapy response in HCC, therefore establishing a unique prognostic model for clinical assessment of HCC patients.